Non-steroidal anti-inflammatory drugs (NSAIDs) are well known to be associated with
serious upper gastrointestinal complications, such as peptic ulcer, bleeding, perforation, and …

The use of non-steroidal anti-inflammatory drugs (NSAIDs) is widespread worldwide thanks
to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is …

Background Acute lower gastrointestinal bleeding is a common reason for emergency
hospital admission, and identification of patients at low risk of harm, who are therefore …

Background Aspirin increases the risk of gastrointestinal bleeding. Aim To investigate the
risk of lower gastrointestinal bleeding (LGIB) in aspirin users. Methods Low‐dose (75‐325 …

Introduction: Gastrointestinal bleeding (GIB) is a major problem in patients on oral
anticoagulation therapy. This issue has become even more pressing since the introduction …

Background and Aims Lower GI bleeding (LGIB) is a common cause of morbidity and
mortality. Colonoscopy is indicated in all hospitalized patients with LGIB, yet the time frame …

The intestinal microbiota might contribute to enteropathy associated with use of nonsteroidal
anti-inflammatory drugs (NSAIDs), but there have been few human studies of this …

Background There are limited data to predict which patients with lower gastrointestinal
bleeding are at risk for adverse outcomes. We aimed to develop a clinical tool based on …

The liver is an important organ of the body, which has a vital role in metabolic functions. The
non‐steroidal anti‐inflammatory drug (NSAID), diclofenac causes hepato‐renal toxicity and …

Colonoscopy continues to be an essential diagnostic and therapeutic tool in the
management of lower gastrointestinal bleeding (LGIB). Studies that have evaluated the role …